Managing a portfolio of interdependent new product candidates in the pharmaceutical industry

被引:132
|
作者
Blau, GE [1 ]
Pekny, JF
Varma, VA
Bunch, PR
机构
[1] Purdue Univ, Dept Chem Engn, W Lafayette, IN 47908 USA
[2] Lilly Res Labs, Indianapolis, IN USA
关键词
D O I
10.1111/j.0737-6782.2004.00075.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Highly regulated industries such as pharmaceuticals and agrochemicals face the challenge of maintaining a Ocontinuous stream of new products. This is difficult because of low probabilities of technical success, high development costs, uncertain market impact, a scarcity of good new product ideas, and limited human and capital resources available to develop them. The problem of evaluating and selecting which new products to develop and then of sequencing or of scheduling them is complicated further by the presence of dependencies between products both in the market place and in the development process itself. This study proposes a portfolio management approach that selects a sequence of projects, which maximizes the expected economic returns at an acceptable level of risk for a given level of resources in a new product development pipeline. A probabilistic network model of distinct activities is used to capture all the activities and resources required in the "process" of developing a new drug. A prioritization scheme suggesting sequences for developing new independent drug candidates with unlimited resources is generated with a conventional bubble chart approach. These sequences initiate a genetic algorithm (GA)-based search for the optimal sequence in the presence of product dependencies and limited resources. By statistically evaluating the sequences generated during the GA search using a discrete event simulation model, it is possible to construct an economic reward-risk frontier that illustrates the trade-offs between expected rewards and risks. The model ideally is suited to answer various "what if" questions relative to changes in the resource level on pipeline performance. The methodology is illustrated with an industrially motivated case study, involving nine interdependent new product candidates targeting three diseases. The dramatic results yield a candidate sequence with an expected return 28 percent higher than the sequence suggested by the bubble chart approach at almost the same level of risk. The synergism among the candidate dependencies, pipeline resources, and economic and technical uncertainties demonstrates the necessity of a computationally intensive approach if the best development strategy is to be realized.
引用
收藏
页码:227 / 245
页数:19
相关论文
共 50 条
  • [1] A product portfolio approach in the pharmaceutical industry
    Rotstein, GE
    Papageorgiou, LG
    Shah, N
    Murphy, DC
    Mustafa, R
    COMPUTERS & CHEMICAL ENGINEERING, 1999, 23 : S883 - S886
  • [2] New Product Development with Discrete Event Simulation: Application to Portfolio Management for the Pharmaceutical Industry
    Perez-Escobedo, J. L.
    Azzaro-Pantel, C.
    Pibouleau, L.
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2011, 50 (18) : 10615 - 10629
  • [3] A 2-phase interdependent methodology for sustainable project portfolio planning in the pharmaceutical industry
    Salehi, Faraz
    Al-e-Hashem, S. Mohammad J. Mirzapour
    Husseini, S. Mohammad Moattar
    COMPUTERS & INDUSTRIAL ENGINEERING, 2022, 174
  • [4] Determinants of New Product Launch Success in the Pharmaceutical Industry
    Minna Matikainen
    Tarja Rajalahti
    Marikki Peltoniemi
    Petri Parvinen
    Anne Juppo
    Journal of Pharmaceutical Innovation, 2015, 10 : 175 - 189
  • [5] Multiobjective strategies for New Product Development in the pharmaceutical industry
    Perez-Escobedo, Jose L.
    Azzaro-Pantel, Catherine
    Pibouleau, Luc
    COMPUTERS & CHEMICAL ENGINEERING, 2012, 37 : 278 - 296
  • [6] Determinants of New Product Launch Success in the Pharmaceutical Industry
    Matikainen, Minna
    Rajalahti, Tarja
    Peltoniemi, Marikki
    Parvinen, Petri
    Juppo, Anne
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2015, 10 (02) : 175 - 189
  • [7] MANAGING NEW-PRODUCT ANNOUNCEMENTS IN THE COMPUTER INDUSTRY
    RABINO, S
    MOORE, TE
    INDUSTRIAL MARKETING MANAGEMENT, 1989, 18 (01) : 35 - 43
  • [8] Proposal of managerial standards for new product portfolio management in Brazilian pharmaceutical companies
    Moreira, Raquel Assis
    Cheng, Lin Chih
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (01) : 53 - 66
  • [9] Patent prosecution and portfolio management in the pharmaceutical industry
    Weingarten, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [10] PRODUCT PORTFOLIO OPTIMIZATION FOR DAIRY INDUSTRY
    Vaklieva-Bancheva, Natasha G.
    Shopova, Elisaveta G.
    Espuna, Antonio
    Puigjaner, Luis
    INTERNATIONAL MEDITERRANEAN MODELLING MULTICONFERENCE 2006, 2006, : 101 - +